Veramed, 245 1st St, Ste 1800, Cambridge, MA 02142, US

Avectas is a cutting-edge biotechnology company based in Cambridge, MA, specializing in the development of a revolutionary non-viral delivery platform for cell engineering. Their Solupore system enables the advancement of next-generation cell therapies by enhancing cell health and functionality, allowing for complex editing and efficient cargo delivery. With a focus on easy integration into existing GMP processes, Avectas is dedicated to accelerating the translation of life-saving therapies to patients. Driven by their commitment to the future of cell therapy, Avectas offers a flexible and easy-to-integrate delivery platform that produces healthier and more functional cells for patients. Their non-viral delivery technology excels at complex editing and challenging cargo delivery, ensuring the realization of the next generation of cell therapies. Through partnerships with companies and researchers in the field, Avectas aims to improve patient outcomes by actively engaging in the development of gene-modified cell therapy products.Generated from the website

Int'l Subsidiary Development

Virtutech

Pamgene

Asischem Inc